News Survey results: The global MECP2 Duplication community speaks Research into MECP2 duplication syndrome has reached an unprecedented milestone: the entry into the world of Read more » June 12, 2025
News Promising early results from the HERO Trial for MECP2 Duplication Syndrome Earlier this year, Alvin Luk took part in the CRISPR Medicine conference in Copenhagen to present the latest developments in CRISPR. Read more » May 20, 2025